Skip to main content

Upstream Bio, Inc.

UPB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002022626

In the last 90 days, Upstream Bio, Inc. insiders filed 0 open-market purchases and 5 sales; 134 institutions reported holding it in 13F filings for Q3 2026, worth $253.3M in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Upstream Bio, Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Upstream Bio, Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 10, 202610-Q–Sep 30, 2026SECIndex
Nov 10, 20268-K2.029.01Nov 10, 2026SECIndex
Sep 1, 20268-K7.018.019.01Sep 1, 2026SECIndex
Aug 11, 202610-Q–Jun 30, 2026SECIndex
Aug 11, 20268-K2.029.01Aug 11, 2026SECIndex
Jun 10, 20268-K5.07Jun 9, 2026SECIndex
May 13, 202610-Q–Mar 31, 2026SECIndex
May 13, 20268-K2.029.01May 13, 2026SECIndex
Mar 26, 20268-K1.019.01Mar 26, 2026SECIndex
Mar 26, 202610-K–Dec 31, 2025SECIndex
Mar 26, 20268-K2.029.01Mar 26, 2026SECIndex
Feb 11, 20268-K2.027.019.01Feb 11, 2026SECIndex
Feb 11, 20268-K7.018.019.01Feb 11, 2026SECIndex
Nov 5, 202510-Q–Sep 30, 2025SECIndex
Nov 5, 20258-K2.029.01Nov 5, 2025SECIndex
Sep 2, 20258-K7.018.019.01Sep 2, 2025SECIndex
Aug 6, 202510-Q–Jun 30, 2025SECIndex
Aug 6, 20258-K2.029.01Aug 6, 2025SECIndex
Jun 12, 20258-K5.07Jun 10, 2025SECIndex
May 6, 202510-Q–Mar 31, 2025SECIndex
May 6, 20258-K2.029.01May 6, 2025SECIndex
Mar 12, 202510-K–Dec 31, 2024SECIndex
Mar 12, 20258-K2.029.01Mar 12, 2025SECIndex
Nov 7, 202410-Q–Sep 30, 2024SECIndex
Nov 7, 20248-K2.029.01Nov 7, 2024SECIndex
Oct 15, 20248-K5.039.01Oct 10, 2024SECIndex